SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Contract win

23 Nov 2011 07:00

RNS Number : 5865S
Porvair PLC
23 November 2011
 



For immediate release 23 November 2011

 

 

 

Porvair PLC

 

Significant Contract Win

 

Porvair filtration technology selected for Posco Gwangyang gasification project

 

Porvair plc ("Porvair" or "the Group"), the specialist filtration and environmental technology group, today announces that its Microfiltration division has signed an agreement with POSCO E&C to supply char filtration equipment to POSCO's Gwangyang, South Korean coal-to-substitute natural gas (SNG) project. The project, with POSCO E&C, a division of POSCO, one of the world's largest steel makers, will generate substantial revenues over the next three years for Porvair.

 

The Gwangyang facility, once built, will produce 500,000 metric tons of pipeline quality SNG from the gasification of approximately 1.8 million tons of coal annually. The plant will use Porvair's design for its char filtration package to remove fly ash during the gasification process. Under the agreement, Porvair will supply all designs as well as filters and ancillary equipment. Porvair will become POSCO E&C's preferred supplier for future SNG facilities.

 

Gasification is a fast growing industrial process, with 25% capacity growth between 2009 and 2011 (source: the Gasification Technologies Council 2011), almost all of which is in Asia and the Americas. Porvair has unmatched experience in the design and manufacture of hot gas (above 300° C) filtration systems for gasification processes, such as the process utilised at Gwangyang, and has considerable proven run-time over a period of more than ten years.

 

Ben Stocks, CEO of Porvair plc commented: "This is a significant contract for Porvair, in a market that we have been developing steadily for several years. Depending on final configuration it will generate revenues of $10-15 million. We will start manufacturing early in 2012, with first deliveries due at the end of the year and subsequent deliveries stretching out through 2013. Order books across the business are currently healthy, and this work with POSCO will go some way to underpinning our order position over the next two years."

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, CEO

Chris Tyler, Group Finance Director

 

Peel Hunt

 

 

 

020 7418 8900

Dan Harris

 

Buchanan

Charles Ryland, Catherine Breen

020 7466 5000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFESFWEFFSEEF
Date   Source Headline
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn
9th Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:35 pmRNSPrice Monitoring Extension
7th Sep 20226:05 pmRNSDirector/PDMR Shareholding
6th Sep 20224:40 pmRNSHolding(s) in Company
2nd Sep 20223:06 pmRNSHolding(s) in Company
10th Aug 20224:40 pmRNSSecond Price Monitoring Extn
10th Aug 20224:36 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSDirector Declaration
5th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:00 amRNSHalf Year Results 2022
30th Jun 20222:15 pmRNSDirector/PDMR Shareholding
29th Apr 20224:41 pmRNSSecond Price Monitoring Extn
29th Apr 20224:36 pmRNSPrice Monitoring Extension
28th Apr 20227:00 amRNSDirector/PDMR Shareholding
14th Apr 20221:42 pmRNSAGM resolutions
14th Apr 20227:00 amRNSAGM Trading Update
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSBlock listing Interim Review
28th Feb 20227:00 amRNSTotal Voting Rights
4th Feb 20223:00 pmRNSDirector/PDMR Shareholding
4th Feb 202212:20 pmRNSGrant of LTSP awards
3rd Feb 202211:27 amRNSDirector/PDMR Shareholding
31st Jan 20227:00 amRNSResults for the year ended 30 November 2021
14th Dec 202112:25 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.